These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
406 related items for PubMed ID: 33682961
41. Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer. Dinh TK, Fendler W, Chałubińska-Fendler J, Acharya SS, O'Leary C, Deraska PV, D'Andrea AD, Chowdhury D, Kozono D. Radiat Oncol; 2016 Apr 27; 11():61. PubMed ID: 27117590 [Abstract] [Full Text] [Related]
42. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance. Li C, Yin Y, Liu X, Xi X, Xue W, Qu Y. Oncotarget; 2017 Apr 11; 8(15):24564-24578. PubMed ID: 28445945 [Abstract] [Full Text] [Related]
43. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer. Leidinger P, Brefort T, Backes C, Krapp M, Galata V, Beier M, Kohlhaas J, Huwer H, Meese E, Keller A. Oncotarget; 2016 Jan 26; 7(4):4611-23. PubMed ID: 26672767 [Abstract] [Full Text] [Related]
44. No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People. Tian F, Shen Y, Chen Z, Li R, Ge Q. Biomed Res Int; 2017 Jan 26; 2017():1304816. PubMed ID: 28656135 [Abstract] [Full Text] [Related]
45. Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K/AKT signalling pathway. Liu X, Jiang T, Li X, Zhao C, Li J, Zhou F, Zhang L, Zhao S, Jia Y, Shi J, Gao G, Li W, Zhao J, Chen X, Su C, Ren S, Zhou C. J Cell Mol Med; 2020 Jan 26; 24(2):1529-1540. PubMed ID: 31894895 [Abstract] [Full Text] [Related]
52. Tumor-derived exosomal circRNA_102481 contributes to EGFR-TKIs resistance via the miR-30a-5p/ROR1 axis in non-small cell lung cancer. Yang B, Teng F, Chang L, Wang J, Liu DL, Cui YS, Li GH. Aging (Albany NY); 2021 May 05; 13(9):13264-13286. PubMed ID: 33952725 [Abstract] [Full Text] [Related]
53. Potential circulating miRNA signature for early detection of NSCLC. Arab A, Karimipoor M, Irani S, Kiani A, Zeinali S, Tafsiri E, Sheikhy K. Cancer Genet; 2017 Oct 05; 216-217():150-158. PubMed ID: 29025589 [Abstract] [Full Text] [Related]
57. Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer. Qu L, Li L, Zheng X, Fu H, Tang C, Qin H, Li X, Wang H, Li J, Wang W, Yang S, Wang L, Zhao G, Lv P, Lei Y, Zhang M, Gao H, Song S, Liu X. Oncotarget; 2017 Jul 11; 8(28):45807-45824. PubMed ID: 28496005 [Abstract] [Full Text] [Related]
58. Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer. Nigita G, Distefano R, Veneziano D, Romano G, Rahman M, Wang K, Pass H, Croce CM, Acunzo M, Nana-Sinkam P. Sci Rep; 2018 Jul 05; 8(1):10222. PubMed ID: 29976955 [Abstract] [Full Text] [Related]
59. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC. Proc Natl Acad Sci U S A; 2009 Jul 21; 106(29):12085-90. PubMed ID: 19597153 [Abstract] [Full Text] [Related]
60. Exosomal EGFR and miR-381-3P Mediate HPV-16 E7 Oncoprotein-Induced Angiogenesis of Non-Small Cell Lung Cancer. Zhan R, Yu H, Zhang G, Ding Q, Li H, Li X, Tang X. Front Biosci (Landmark Ed); 2024 May 15; 29(5):189. PubMed ID: 38812317 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]